Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Repeat Propess for cervical ripening vs single Propess followed by oxytocin
2016-000147-13Phase 3Terminated
- Sponsor
- CHU de Limoges
- Start
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of Propess in cervical ripening (CR) (2 arms), sponsored by CHU de Limoges. Primary endpoint: Rate of vaginal deliveries. Started Apr 2016; status: terminated.
02
Drugs
Propess
03
Conditions
cervical ripening (CR)
Beyond the preview
Go deeper on 2016-000147-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-000147-13.